1. Home
  2. GRBK vs TMDX Comparison

GRBK vs TMDX Comparison

Compare GRBK & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GRBK
  • TMDX
  • Stock Information
  • Founded
  • GRBK 2006
  • TMDX 1998
  • Country
  • GRBK United States
  • TMDX United States
  • Employees
  • GRBK N/A
  • TMDX N/A
  • Industry
  • GRBK Homebuilding
  • TMDX Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • GRBK Consumer Discretionary
  • TMDX Health Care
  • Exchange
  • GRBK Nasdaq
  • TMDX Nasdaq
  • Market Cap
  • GRBK 2.6B
  • TMDX 2.3B
  • IPO Year
  • GRBK N/A
  • TMDX 2019
  • Fundamental
  • Price
  • GRBK $59.67
  • TMDX $73.11
  • Analyst Decision
  • GRBK Hold
  • TMDX Buy
  • Analyst Count
  • GRBK 3
  • TMDX 10
  • Target Price
  • GRBK $65.50
  • TMDX $118.44
  • AVG Volume (30 Days)
  • GRBK 286.8K
  • TMDX 761.9K
  • Earning Date
  • GRBK 04-30-2025
  • TMDX 04-29-2025
  • Dividend Yield
  • GRBK N/A
  • TMDX N/A
  • EPS Growth
  • GRBK 37.62
  • TMDX N/A
  • EPS
  • GRBK 8.45
  • TMDX 1.01
  • Revenue
  • GRBK $2,098,943,000.00
  • TMDX $441,540,000.00
  • Revenue This Year
  • GRBK $5.34
  • TMDX $25.33
  • Revenue Next Year
  • GRBK $7.55
  • TMDX $20.53
  • P/E Ratio
  • GRBK $7.00
  • TMDX $67.59
  • Revenue Growth
  • GRBK 18.07
  • TMDX 82.74
  • 52 Week Low
  • GRBK $51.76
  • TMDX $55.00
  • 52 Week High
  • GRBK $84.66
  • TMDX $177.37
  • Technical
  • Relative Strength Index (RSI)
  • GRBK 52.23
  • TMDX 57.27
  • Support Level
  • GRBK $56.80
  • TMDX $65.90
  • Resistance Level
  • GRBK $60.50
  • TMDX $73.68
  • Average True Range (ATR)
  • GRBK 1.62
  • TMDX 3.45
  • MACD
  • GRBK 0.05
  • TMDX 0.24
  • Stochastic Oscillator
  • GRBK 79.68
  • TMDX 93.25

About GRBK Green Brick Partners Inc.

Green Brick Partners Inc is a homebuilding and land development company. It acquires and develops land, as well as provides land and construction financing to its controlled builders. The company has three reportable segments: builder operations central, builder operations southeast, and land development. The majority of the company's revenue is generated from the builder operations central segment which is entirely the operations of builders in Texas. The company is engaged in various aspects of the homebuilding process, including land acquisition and development, entitlements, design, construction, marketing, sales, and brand image creation. In addition to homebuilding, the company provides home financing services, such as mortgage and title, through its subsidiaries.

About TMDX TransMedics Group Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

Share on Social Networks: